Cost-effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health-related quality of life.
Anju Devianee KeetharuthRebecca L GouldChristopher J McDermottBenjamin J ThompsonCharlotte RawlinsonMike BradburnMatt BursnallPavithra KumarEmily J TurtonPaul TappendenDavid WhiteRobert J HowardMarc A SerfatyLance M McCrackenChristopher D GrahamAmmar Al-ChalabiLaura H GoldsteinVanessa LawrenceCindy CooperTracey Youngnull nullPublished in: European journal of neurology (2024)
Despite the intervention being cost-ineffective in the primary analysis, the significant difference in the effects measured by MQOL-R, the low costs of the intervention, the results in the subgroup analysis, and the fact that ACT was shown to improve the quality of life for people living with MND, suggest that ACT could be incorporated into MND clinical services.